Skip to menu Skip to content Skip to footer
Dr

George Therapondos

Email: 

Overview

Availability

Dr George Therapondos is:
Available for supervision

Works

Search Professor George Therapondos’s works on UQ eSpace

184 works between 1997 and 2025

101 - 120 of 184 works

2008

Conference Publication

DONOR AGE AFFECTS RESPONSE TO ANTIVIRAL THERAPY IN PATIENTS WITH RECURRENT HEPATITIS C FOLLOWING LIVER TRANSPLANTATION

Lilly, Leslie, Therapondos, George, Selzner, Nazio, Levy, Gary A. and Renner, Eberhard L. (2008). DONOR AGE AFFECTS RESPONSE TO ANTIVIRAL THERAPY IN PATIENTS WITH RECURRENT HEPATITIS C FOLLOWING LIVER TRANSPLANTATION. 59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, San Francisco Ca, Oct 31-Nov 04, 2008. HOBOKEN: WILEY.

DONOR AGE AFFECTS RESPONSE TO ANTIVIRAL THERAPY IN PATIENTS WITH RECURRENT HEPATITIS C FOLLOWING LIVER TRANSPLANTATION

2008

Conference Publication

A HIGH MELD SCORE IS NOT A CONTRAINDICATION FOR RIGHT LOBE ADULT LIVING DONOR LIVER TRANSPLANTATION

Selzner, Markus, Selzner, Nazia, Greig, Paul D., Therapondos, George, Cattral, Mark S., Adcock, Lesley E., Lilly, Leslie, McGilvray, Ian, Renner, Eberhard L., Kashfi, Arash, Levy, Gary A. and Grant, David (2008). A HIGH MELD SCORE IS NOT A CONTRAINDICATION FOR RIGHT LOBE ADULT LIVING DONOR LIVER TRANSPLANTATION. 59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, San Francisco Ca, Oct 31-Nov 04, 2008. HOBOKEN: JOHN WILEY & SONS INC.

A HIGH MELD SCORE IS NOT A CONTRAINDICATION FOR RIGHT LOBE ADULT LIVING DONOR LIVER TRANSPLANTATION

2008

Conference Publication

TENOFOVIR IS EFFECTIVE IN SUPPRESSING HBV REPLICATION IN LIVER TRANSPLANT RECIPIENTS WITH NUCLEOS(T)IDE RESISTANT RECURRENT DISEASE

Lilly, Leslie, Therapondos, George, Mason, Andrew L. and Burak, Kelly W. (2008). TENOFOVIR IS EFFECTIVE IN SUPPRESSING HBV REPLICATION IN LIVER TRANSPLANT RECIPIENTS WITH NUCLEOS(T)IDE RESISTANT RECURRENT DISEASE. 59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, San Francisco Ca, Oct 31-Nov 04, 2008. HOBOKEN: WILEY.

TENOFOVIR IS EFFECTIVE IN SUPPRESSING HBV REPLICATION IN LIVER TRANSPLANT RECIPIENTS WITH NUCLEOS(T)IDE RESISTANT RECURRENT DISEASE

2008

Conference Publication

ICU DEPENDENCY DOES NOT PREDICT FUTILITY OF LIVER TRANSPLANTATION (OLT) IN PATIENTS WITH END-STAGE CHRONIC LIVER DISEASE (ESCLD)

Selzner, Markus, Kashfi, Arash, Selzner, Nazia, Greig, Paul D., Therapondos, George, Cattral, Mark S., Adcock, Lesley E., Lilly, Leslie, McGilvray, Ian, Levy, Gary A., Renner, Eberhard L. and Grant, David (2008). ICU DEPENDENCY DOES NOT PREDICT FUTILITY OF LIVER TRANSPLANTATION (OLT) IN PATIENTS WITH END-STAGE CHRONIC LIVER DISEASE (ESCLD). 59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, San Francisco Ca, Oct 31-Nov 04, 2008. HOBOKEN: JOHN WILEY & SONS INC.

ICU DEPENDENCY DOES NOT PREDICT FUTILITY OF LIVER TRANSPLANTATION (OLT) IN PATIENTS WITH END-STAGE CHRONIC LIVER DISEASE (ESCLD)

2008

Conference Publication

END OF TREATMENT RESPONSE TO ANTIVIRAL THERAPY STABILIZES FIBROSIS IN RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION FOR AT LEAST ONE YEAR

Selzner, Nazia, Guindi, Maha, Leslie, Lilly, Adeyi, Oyedele, Therapondos, George, Kashfi, Arash, Selzner, Markus, Ian, McGilvray, Greig, Paul, Cattral, Mark, Grant, David, Levy, Gary and Renner, Eberhard L. (2008). END OF TREATMENT RESPONSE TO ANTIVIRAL THERAPY STABILIZES FIBROSIS IN RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION FOR AT LEAST ONE YEAR. Joint International Congress of the ILTS, ELITA, AND LICAGE, Paris France, Jul 09-12, 2008. HOBOKEN: WILEY.

END OF TREATMENT RESPONSE TO ANTIVIRAL THERAPY STABILIZES FIBROSIS IN RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION FOR AT LEAST ONE YEAR

2008

Conference Publication

INCREASED BMI PER SE DOES NOT INCREASE DONOR RISK IN RIGHT LOBE LIVING LIVER DONATION

Selzner, Markus, Adcock, Lesley E., McGilvray, Ian D., Selzner, Nazia, Cattral, Mark S., Therapondos, George, Lilly, Les, Greig, Paul D., Kashfi, Arash, Renner, Eberhard L., Levy, Gary A. and Grant, David R. (2008). INCREASED BMI PER SE DOES NOT INCREASE DONOR RISK IN RIGHT LOBE LIVING LIVER DONATION. Joint International Congress of the ILTS, ELITA, AND LICAGE, Paris France, Jul 09-12, 2008. HOBOKEN: JOHN WILEY & SONS INC.

INCREASED BMI PER SE DOES NOT INCREASE DONOR RISK IN RIGHT LOBE LIVING LIVER DONATION

2008

Conference Publication

A HIGH MELD SCORE IS NOT A CONTRA INDICATION FOR RIGHT LOBE ADULT LIVING DONOR LIVER TRANSPLANTATION

Selzner, Markus, Selzner, Nazia, Greig, Paul D., Therapondos, George, Cattral, Mark S., Adcock, Lesley E., Lilly, Les, McGilvray, Ian D., Renner, Eberhard L., Kashfi, Arash, Levy, Gary A. and Grant, David R. (2008). A HIGH MELD SCORE IS NOT A CONTRA INDICATION FOR RIGHT LOBE ADULT LIVING DONOR LIVER TRANSPLANTATION. Joint International Congress of the ILTS, ELITA, AND LICAGE, Paris France, Jul 09-12, 2008. HOBOKEN: JOHN WILEY & SONS INC.

A HIGH MELD SCORE IS NOT A CONTRA INDICATION FOR RIGHT LOBE ADULT LIVING DONOR LIVER TRANSPLANTATION

2008

Conference Publication

Successful antiviral therapy for recurrent hepatitis C after liver transplantation stops progression of fibrosis

Selzner, Nazia, Adeyi, Oyedele, Lilly, Leslie, Herath, Chaturika, Gurrarn, Krishna, Therapondos, George, Kashfi, Arash, McGilvray, Fail, Greig, Paul, Cattral, Mark, Selznerl, Markus, Guindi, Maha, Grant, David, Levy, Gary and Renner, Eberhard L. (2008). Successful antiviral therapy for recurrent hepatitis C after liver transplantation stops progression of fibrosis. 8th American Transplant Congress, Toronto Canada, May 31-Jun 04, 2008. HOBOKEN: WILEY.

Successful antiviral therapy for recurrent hepatitis C after liver transplantation stops progression of fibrosis

2008

Journal Article

Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens

Dubay, Derek, Smith, Rob J., Qiu, Kenneth G., Levy, Gary A., Lilly, Leslie and Therapondos, George (2008). Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens. Liver Transplantation, 14 (5), 651-659. doi: 10.1002/lt.21429

Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens

2008

Conference Publication

Anonymous living liver donors: An alternate option

Adcock, Lesley E., Therapondos, George, Levy, Gary A., Macleod, Cailin, Greenwood, Sarah, Renner, Eberhard, Grant, David and Abbey, Susan (2008). Anonymous living liver donors: An alternate option. 8th American Transplant Congress, Toronto Canada, May 31-Jun 04, 2008. OXFORD: BLACKWELL PUBLISHING.

Anonymous living liver donors: An alternate option

2008

Conference Publication

Multicentre randomised controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed

Tripathi, D., Ferguson, J. W., Kochar, N., Leithead, J., Therapondos, G., Mcavoy, N., Stanley, A., Forrest, E. H., Hislop, W. S., Mills, P. R. and Hayes, P. C. (2008). Multicentre randomised controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed. GLASGOW: SCOTTISH MEDICAL JOURNAL.

Multicentre randomised controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed

2008

Conference Publication

The use of older donors for right lobe living donor liver transplantation adversely affects biliary complications, but not patient or graft survival

Selzner, Markus, Cattral, Mark S., McGilvray, Ian D., Greig, Paul D., Adcock, Lesley E., Kashfi, Arash, Selzner, Nazia, Renner, Eberhard L., Lilly, Les, Therapondos, George, Levy, Gary A. and Grant, David R. (2008). The use of older donors for right lobe living donor liver transplantation adversely affects biliary complications, but not patient or graft survival. 8th American Transplant Congress, Toronto Canada, May 31-Jun 04, 2008. OXFORD: BLACKWELL PUBLISHING.

The use of older donors for right lobe living donor liver transplantation adversely affects biliary complications, but not patient or graft survival

2008

Conference Publication

Angiotensin-blocking agents do not slow down fibrosis progression in recurrent hepatitis C after liver transplantation

Gurram, Krishna C., Selznar, Nazia, Adeyi, Odeli, Guindi, Malta, Lilly, Les, Therapondos, Geroge, Khasfi, Arash, Nanji, Sulaiman, Levy, Gary and Renner, Eberhard (2008). Angiotensin-blocking agents do not slow down fibrosis progression in recurrent hepatitis C after liver transplantation. 8th American Transplant Congress, Toronto Canada, May 31-Jun 04, 2008. OXFORD: BLACKWELL PUBLISHING.

Angiotensin-blocking agents do not slow down fibrosis progression in recurrent hepatitis C after liver transplantation

2008

Conference Publication

Liver transplantation for patients with hepatocellular carcinoma that exceed the Milan criteria

DuBay, Derek, Cleary, Sean, Greig, Paul, Cattral, Mark, McGilvray, Ian, Therapondos, George, Renner, Ederhard, Lilly, Lesley, Levy, Gary and Grant, David (2008). Liver transplantation for patients with hepatocellular carcinoma that exceed the Milan criteria. 8th American Transplant Congress, Toronto Canada, May 31-Jun 04, 2008. OXFORD: BLACKWELL PUBLISHING.

Liver transplantation for patients with hepatocellular carcinoma that exceed the Milan criteria

2008

Conference Publication

Improved survival in liver transplant recipients (LT) treated for recurrent hepatitis C (HCV) is seen in both relapsers and in sustained responders

Lilly, Les, Selzner, Nazia, Therapondos, George, Renner, Eberhard L., Selzner, Marcus, McGilvray, Ian, Greig, Paul D., Cattral, Mark S., Grant, David R. and Levy, Gary A. (2008). Improved survival in liver transplant recipients (LT) treated for recurrent hepatitis C (HCV) is seen in both relapsers and in sustained responders. 8th American Transplant Congress, Toronto Canada, May 31-Jun 04, 2008. HOBOKEN: WILEY.

Improved survival in liver transplant recipients (LT) treated for recurrent hepatitis C (HCV) is seen in both relapsers and in sustained responders

2008

Conference Publication

Right lobe live liver donation is safe in selected subjects older than 55 years

Selzner, Markus, Adcock, Lesley E., Greig, Paul D., Selzner, Nazia, Cattral, Mark S., Renner, Eberhard L., McGilvray, Ian D., Therapondos, George, Lilly, Les, Levy, Gary A. and Grant, David R. (2008). Right lobe live liver donation is safe in selected subjects older than 55 years. 8th American Transplant Congress, Toronto Canada, May 31-Jun 04, 2008. OXFORD: BLACKWELL PUBLISHING.

Right lobe live liver donation is safe in selected subjects older than 55 years

2007

Conference Publication

Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low dose calcineurin inhibitors

Dubay, Derek, Lilly, Leslie, Smith, Robert, Levy, Gory A. and Therapondos, George (2007). Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low dose calcineurin inhibitors. 58th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Boston Ma, Nov 02-06, 2007. HOBOKEN: WILEY.

Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low dose calcineurin inhibitors

2007

Conference Publication

Sustained virological response in patients successfully treated for recurrent hepatitis C following liver transplantation 15 highly durable

Lilly, Les, Girgrah, Nigel and Therapondos, George (2007). Sustained virological response in patients successfully treated for recurrent hepatitis C following liver transplantation 15 highly durable. 58th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Boston Ma, Nov 02-06, 2007. HOBOKEN: JOHN WILEY & SONS INC.

Sustained virological response in patients successfully treated for recurrent hepatitis C following liver transplantation 15 highly durable

2007

Conference Publication

Multicenter randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed

Tripathi, Dhiraj, Ferguson, James W., Kochar, Narendra, Leithead, Joanna A., Therapondos, George, McAvoy, Norma C., Stanley, Adrian J., Forrest, Ewan H., Hislop, S. W., Mills, Peter R. and Hayes, Peter C. (2007). Multicenter randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed. 58th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Boston Ma, Nov 02-06, 2007. HOBOKEN: WILEY-BLACKWELL.

Multicenter randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed

2007

Conference Publication

Mycophenolate mofetil (MMF) toxicity-related dose reductions associated with increased rates of acute rejection. Data from a large multiorgan transplant centre

Therapondos, George, Sheedy, Jill, Smith, Robert J., Ross, Heather J., Singer, Lianne G., Schiff, Jeffrey, Cattral, Mark S., Cole, Edward H. and Levy, Gary A. (2007). Mycophenolate mofetil (MMF) toxicity-related dose reductions associated with increased rates of acute rejection. Data from a large multiorgan transplant centre. OXFORD: BLACKWELL PUBLISHING.

Mycophenolate mofetil (MMF) toxicity-related dose reductions associated with increased rates of acute rejection. Data from a large multiorgan transplant centre

Supervision

Availability

Dr George Therapondos is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Media

Enquiries

For media enquiries about Dr George Therapondos's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au